Many activating immunoreceptors associate with signaling adaptor molecules like FceR1γ or CD247. FceR1γ and CD247 share high sequence homology and form disulphide-linked homodimers that contain a pair of acidic aspartic acid residues in their transmembrane (TM) domains that mediate assembly, via interaction with an arginine residue at a similar register to these aspartic acids, with the activating immunoreceptors. However, this model cannot hold true for receptors like CD16A, whose TM domains do not contain basic residues. We have carried out an extensive site-directed mutagenesis analysis of the CD16A receptor complex and now report that the association of receptor with the signaling adaptor depends on a network of polar and aromatic residues along the length of the TM domain. Molecular modeling indicates that CD16A TM residues F 202 , D
, D 205 , and T 206 form the core of the membrane-embedded trimeric interface by establishing highly favorable contacts to the signaling modules through rearrangement of a hydrogen bond network previously identified in the CD247 TM dimer solution NMR structure. Strikingly, the amino acid D 205 also regulates the turnover and surface expression of CD16A in the absence of FceR1γ or CD247. Modeling studies indicate that similar features underlie the association of other activating immune receptors, including CD64 and FceR1α, with signaling adaptor molecules, and we confirm experimentally that equivalent F, D, and T residues in the TM domain of FceR1α markedly influence the biology of this receptor and its association with FceR1γ.
activating immunoreceptors | signaling adaptor molecules | Fc receptors | transmembrane interactions H uman FcγRIIIA (CD16A) is a low-affinity receptor for the Fc portion of IgG expressed by human CD56 dim natural killer (NK) cells, subsets of monocytes, dendritic cells, and rare T cells. FcγRIIIB (CD16B) is encoded by a distinct gene and is preferentially expressed by neutrophils (1) . CD16B is a GPI-anchored glycoprotein whereas CD16A is a type 1 membrane glycoprotein with a single transmembrane (TM) domain and a short cytoplasmic tail whose expression at the cell surface depends on association with the signaling adaptor molecules CD247 (TCRζ) and/or FceR1γ (1) (2) (3) (4) . First discovered as components of the TCR:CD3 complex and the high affinity receptor for IgE, respectively (5-7), CD247 and FceR1γ are integral membrane proteins that have subsequently been found to be obligate signaling adaptors for many immunoreceptors in different cell types. Both adaptors have very short extracellular domains and cytoplasmic tails that contain immunoreceptor tyrosinebased activating motifs (ITAMs) for signal transduction. Moreover, both CD247 and FceR1γ form dimers in the endoplasmic reticulum (ER) that are stabilized by a disulphide bond at the junction between the extracellular and TM domains so that, at the cell surface, CD247 and FceR1γ in complex with their client receptors are dimeric. In general, the receptors known to associate with CD247 and FceR1γ have short intracellular tails and thus are completely dependent on these adaptors to signal, although phosphorylation of a protein kinase C (PKC) motif in the cytoplasmic tail of CD16A can modulate the outcome of receptor ligation (8) .
The incorporation of CD247 into the TCR/CD3 complex is the rate-limiting step in the process of assembly of the receptor complex for cell surface expression because incomplete TCR/CD3 complex is otherwise retained in the cis-Golgi and targeted for degradation (9) . Similarly, association with the FceR1γ or CD247 molecules is also required for the correct maturation and expression at the cell surface of the CD16A protein (2) (3) (4) . The interaction of CD247 with the TCR, like many immunoreceptor complex interactions, occurs via a precise interface involving the TM domains of the different subunits in the complex (10) . Detailed analysis of the interactions underlying the associations between the different subunits of the T-cell receptor complex have shown that interactions between basic and acidic residues localized at precise positions of the TM domains of the different subunits are necessary, and often sufficient, for complex assembly (11) . Subsequent studies on the assembly of NK cell receptor complexes, such as NKG2D-DAP10 (12) or NKG2C-DAP12 (13) , have shown that the association of the subunits in these complexes is also mediated by similar interactions, where pairs of aspartic acids in the adaptor molecules interact with either an Significance Many activating immunoreceptors associate, via interactions between transmembrane domains, with adaptor molecules that mediate signaling for leukocyte activation. To date, the best characterized form of receptor complex assembly depends on a single basic transmembrane (TM) domain residue. We now describe a second, completely different solution for TM-mediated receptor assembly, found in three different Fc receptor TM domains, and involving a more complex polar/aromatic interface. Residues in the core of this interaction motif can also regulate receptor protein turnover. Thus, multiple solutions for TMmediated receptor assembly with signaling modules have evolved. These findings may provide more broadly useful insights into how other immune receptors that do not contain charged residues in their TM domains assemble into complexes with signaling adaptor molecules.
arginine or lysine residue in the receptor TM domain. Indeed, for KIR2DS2 or NKG2D, all residues of the receptor TM domain can be mutated to valine or leucine, and the interactions of the lysine of KIR2DS2, or the arginine of NKG2D, with aspartic acids in DAP12 and DAP10, respectively, are sufficient to maintain the receptor/adaptor complex (14) . Surprisingly, however, the TM domain sequence of CD16A, which is devoid of basic residues and contains an aspartic acid, pairs with FceR1γ and CD247 which also contain aspartic acids in their TM. Thus, a mechanism of assembly between CD16A and FceR1γ or CD247, distinct from those known for other immunoreceptor complexes, must exist.
We examined in detail the TM interactions that mediate association of CD16A with FceR1γ and CD247 signaling molecules and found that multiple polar and aromatic residues, distributed along an extended helical face of the CD16A TM domain, contribute to the receptor/adaptor interaction. Our analysis revealed a particularly important role for the CD16A TM sequence , which constitutes the key CD16A retention/degradation signal, within the interface. Unbiased MD simulations revealed that the related Fc receptors FceR1α and FcγR1 (CD64) likely form similar interfaces with the FceR1γ dimer that include nearly identical interactions mediated by conserved FxxDT (FceR1α) and FxxNT (CD64) TM sequences. We confirmed the importance of this sequence by examining the assembly and surface expression of FceR1α in cells. These results indicate that the concepts identified here may serve as a useful guide to understand the assembly and cell biology of multiple activating immunoreceptor complexes where interactions between amino acids of complementary charge potential are not obviously relevant.
Results

CD16A
Associates with Either FceR1γ or CD247. It has previously been reported that cell surface expression of the CD16A receptor depends on a noncovalent association with the signaling dimers FceR1γ and/or CD247 (2) (3) (4) . Ex vivo analysis of CD16A cell surface expression on primary human NK cells deficient in either FceR1γ or CD247 has suggested that CD16A does not discriminate between these adaptor molecules (15) , and we confirmed these data in vitro when fibroblasts were transfected with CD16A alone or in combination with either FceR1γ or CD247 adaptor molecules. Only small amounts of CD16A protein, which correspond to an immature (EndoH-sensitive) species, were detected in cells transfected with the receptor construct alone (Fig. 1A) , and almost no surface expression of CD16A was observed (Fig. 1B) . In contrast, when the CD16A construct was cotransfected with plasmids driving expression of the FceR1γ or CD247 adaptor molecules, abundant glycosylated and EndoH-resistant CD16A protein was observed (Fig. 1A) . These experiments showed that CD16A was retained in the ER and probably degraded, in the Fig. 1 . CD16A requires association with adaptor modules for cell surface expression but shows no preference for assembly with either CD247 or FceR1γ. An expression vector encoding CD16A was transfected, either alone or in combination with plasmids for CD247 or FceR1γ, into 293T cells, and cell lysates were analyzed by Western blot (A). Aliquots of the same lysates were treated with EndoH endoglycosidase for determination of glycosylation state as a measure of maturation state (A). Representative image of three independent experiments is shown. Surface expression of CD16A was also analyzed by flow cytometry of transfected cells. (B) Percentage of cells expressing CD16 at the cell surface and mean fluorescence intensity (MFI) of CD16 staining was determined using Kaluza Flow Cytometry Analysis Software. Data represent mean of three experiments, and statistical significance was determined using the one-way ANOVA-Tukey´s multiple comparison test (**P < 0.01; ***P < 0.001; n.s., not statistically significant P > 0.05). S methionine and cysteine). These reactions were done in ER-like conditions to allow assembly of the receptor complex. Each completed assembly reaction was then divided in two aliquots: one for HA immunoprecipitation, to quantify total full-length transcribed FceR1γ HA and CD247 HA protein and labeled "INPUT" control in our analysis and the other labeled "IN COMPLEX," where CD16-SBP was immunoprecipitated and associated HA-tagged adaptor molecules could be analyzed. The immunoprecipitates were analyzed in 12% SDS/PAGE gels in nonreducing conditions and transferred to PVDF membranes for phospho-imaging. Dimer and monomer species were quantified, normalized to the number of labeling positions, and plotted as mean ± SD. Statistical significance was calculated using one-way ANOVA. Images are representative of at least three independent experiments. absence of adaptor (Fig. 1A) . Cell-surface expression of CD16A seemed equivalent when either FceR1γ or CD247 was present in the system (Fig. 1B) . Therefore, these data confirm prior work demonstrating that association of the adaptor modules FceR1γ or CD247 with CD16A not only is required for progression of this receptor through the secretory pathway and cell surface expression but also protects the CD16A protein from degradation (16) .
Adaptor Modules FceR1γ and CD247 Are Recruited Equally by CD16A.
To address in detail how the CD16A receptor associates with the FceR1γ or CD247 adaptors, we used an in vitro translation (IVT)-based experimental system that had previously been used to define the assembly of the TCRαβ/CD3eγδ/CD247 complex (11) and several NK receptor complexes (10) . Streptavidin-binding peptide (SBP)-tagged CD16A was cotranslated with either HA-tagged FceR1γ or HA-CD247 in the presence of ER-derived microsomes and 35 S-labeled methionine/cysteine, and then complex formation was quantitated in coimmunoprecipitation experiments (Fig. 1C and Fig. S1 ).
Inspection of the lanes corresponding to "INPUT" controls ( Fig.  1 D and E) showed that HA-tagged FceR1γ and CD247 species ran on nonreducing SDS/PAGE gels as dimers and monomers, but that, after immunoprecipitation of CD16A, the fraction of dimer species was clearly enriched ( Fig. 1 D and E, "IN COMPLEX"). Quantitation of CD16A immunoprecipitates from these reactions confirmed that CD16A preferentially recruited adaptor molecule dimers rather than monomers ( Fig. 1 D and E) . Indeed, because dimerization of CD247 and FceR1γ is driven by polar residues in the TM domain, we cannot exclude the possibility that a proportion of the monomeric species detected after SDS/PAGE were actually noncovalent dimeric species in which the disulphide bond had not yet formed. Experiments in which CD16A was cotranslated with both FceR1γ and CD247 in the same reaction showed once again that dimeric species were highly enriched in CD16A immunoprecipitates, compared with monomeric adaptor molecules (Fig. 1F) . Moreover, after integrating the radioactive signal in each band and correcting for the number of methionine/cysteine labeling positions in each dimeric species, no preference for FceR1γ-FceR1γ, FceR1γ-CD247, or CD247-CD247 dimers was observed, suggesting that CD16A binds FceR1γ and CD247 with similar affinity. This observation suggested that the association of CD16A with these adaptor molecules is mediated by similar protein interactions; this hypothesis was tested in the next set of experiments.
A Polar and Aromatic Interface Mediates the Association of CD16A with Adaptor Modules. To identify the TM residues involved in CD16A association with adaptor modules, a panel of mutants was prepared in three blocks of three mutations. Based on the documented roles of polar and aromatic residues in driving TM helix associations (17, 18) , we mutated these amino acid types in the CD16A TM sequence ( Fig. 2A ) to alanine and evaluated the association of mutants with each signaling molecule using the IVT system described above. All three of the "triple" mutants (S S 211 > A) showed marked defects in association with both FceR1γ and CD247 ( Fig. 2 B and C) . To determine the contribution of specific residues to the defective association of the triple mutants with FceR1γ, a panel of single mutants ( Fig. S2A ) was prepared and tested in quantitative analyses (Fig. 3A) . This panel included a Q 191 > A mutant that had not been tested in the block analysis but caused ∼40% reduction in CD16A association, identifying an additional polar amino acid involved in the assembly. The mutation of S > Ala triple mutant were tested, alteration of the aromatic residues Y 209 and F 210 had the greatest effect on the CD16A-FceR1γ complex formation whereas replacement of S 211 with alanine produced only a mild defect (Fig. 3A) . We tested the same CD16A TM mutants for their effects on association with CD247, and very similar results were obtained (Fig. 3B) , consistent with the high sequence similarity between the TM domains of FceR1γ and CD247 (Fig. 3C) .
Mapping the amino acids that contributed most to the interactions of CD16A with FceR1γ and CD247 onto a helical wheel projection (Fig. 3D) , we observed that these residues are colocated on one face of the receptor TM domain whereas the only two polar residues located on the opposite side of the TM helix (S 193 and S 211 ) had no effect on complex formation. The replacement of C 195 with alanine on the interacting face also had no significant effect, indicating that disruption of the association with adaptor molecules is likely a specific effect of particular mutations rather than a generally disruptive effect of alanine substitution on the TM helix structure. This interpretation is consistent with the view that the helical structure of TM domains is driven primarily by backbone hydrogen bonds and the observation that alanine is, after leucine, the second most common α-helical TM residue (19) . We therefore concluded that interactions between CD16A and its signaling adaptors FceR1γ Fig. 2 . The effects of CD16A triple block mutants on association with CD247 or FceR1γ. Three triple mutants targeting groups of polar and aromatic residues along the length of the CD16A transmembrane domain were prepared (A), and the ability of these mutants to assemble with adaptor modules, FceR1γ or CD247, was evaluated (B and C). After immunoprecipitation using anti-HA antibody, complex formation with FceR1γ (B) and CD247 (C) was analyzed in 12% SDS/PAGE gels in reducing conditions. Then 10% of assembly reactions without immunoprecipitation were analyzed in parallel as loading controls. As can be observed in the gels, dimers of FceR1γ, and especially CD247, were not completely reduced in these conditions. MC, mixing control in which CD16A and FceR1γ/CD247 were translated in separate reactions and mixed just before detergent extraction; N.R., nonreduced. and CD247 are mediated by a specific helical face of the CD16A TM domain that is composed of mostly polar and aromatic amino acids.
Analysis of the Interactions Between CD16A and Signaling Adaptors in Live Cells. Although the IVT technique facilitates highly quantitative comparisons of mutants in receptor assembly, it has the drawback that the use of isolated ER microsomes means that only a fraction of the secretory pathway that membrane proteins must traverse to reach the cell surface is present in these experiments. (Fig. 4A) , consistent with the reduced ability of these mutants to associate with either FceR1γ or CD247 in the IVT experiments (Fig. 3) . Surprisingly, however, the CD16A expression at the cell surface, supporting the conclusion that these residues contribute to the association with FceR1γ and CD247. In contrast, the single change D 205 > A sufficed to permit normal, or increased, levels of CD16A expression at the plasma membrane. Analysis of the NK cell lines NKL and NK92-MI transduced with the same panel of CD16A mutants confirmed these findings (Fig. 4 B and C) (representative FACS plots are shown in Fig. S3 ). These data strongly support the conclusion from IVT experiments that the CD16A TM residues F In these experiments, the CD16A S 193 > A mutant was also expressed at increased levels on the surface of the NKL and NK92-MI cell lines, but not on 293T cells. The IVT data showed that mutation of this amino acid had no effect on the interaction with signaling adaptor molecules, consistent with its predicted location on the opposite side of the TM helix from the residues that do participate directly in the interaction. It is possible that this increased expression simply reflects an increased ability to reach the cell surface due to the substitution of a nonpolar for a polar amino acid in the TM domain, but this hypothesis does not explain why this effect occurs in NK cell lines, but not 293T cells. Thus, we favor the idea that the S 193 > A mutation leads to increased expression of CD16A at the cell surface by modulating the association of this receptor with some other molecule expressed in Fig. 3 . The CD16A-FceR1γ TM interface is dominated by polar and aromatic residues. Triple-and singleresidue CD16A mutants were tested for association with FceR1γ (A) or CD247 (B). Each dot represents an independent experiment where complex formation for WT or the indicated CD16A mutant was quantified. Statistical significance was calculated using one-way ANOVA-Dunnett posttest for multiple comparison (**P < 0.01; ***P < 0.001; n.s., not statistically significant P > 0.05). lymphoid cells (e.g., CD2) (22) , but further experiments will be required to resolve this issue definitively.
The TM Amino Acid D 205 Regulates Intracellular Trafficking of CD16A.
Because CD16A is unable to reach the cell surface in the absence of adaptor modules and is instead degraded, it has been suggested that the association of CD16A with either FceR1γ or CD247 masks a motif in the CD16A TM domain that might direct protein degradation (16) or retention (23) . To test this hypothesis, 293T fibroblasts were transfected with different CD16A TM mutant proteins in the absence of adaptor proteins and analyzed by flow cytometry and Western blot. As previously shown (Fig. 1A) , in the absence of signaling adaptors, WT CD16A accumulates in the ER, and little to no mature glycosylated species or cell surface expression can be detected (Fig. 5) . In these experiments, the S Fig. 5 A and B) or total cellular protein levels ( Fig. 5 C and D) . (Fig. 5A) , and a 3.5-fold increase in levels of both immature and fully glycosylated CD16A protein was detected by Western blot (Fig. 5 C and D) . The CD16A D 205 > A mutant was also expressed at very high levels on the cell surface, and, again, marked increases in the levels of total CD16A protein were obvious on Western blot analysis ( Fig. 5 E and F) . Together with the low surface expression and total cellular protein levels of the F 202 > A and T 206 > A mutants, these data confirm that D 205 is the major TM residue controlling the intracellular retention before eventual degradation of CD16A and support the hypothesis that association with either FceR1γ or CD247 masks this aspartic acid, facilitating export from the ER and expression at the plasma membrane. T 206 > A mutant, which is expressed at higher than WT levels at the cell surface, was nonetheless unable to signal for activation, consistent with the impaired association of this receptor with the FceR1γ and CD247 adaptor molecules observed in IVT experiments (Figs. 2 and 3 ). In contrast, the D 205 > A mutant, which retained some ability to interact with adaptors in IVT experiments (Fig.  3) , was able to trigger NK cell cytotoxicity. However, despite the roughly fivefold higher surface expression of this mutant compared with WT, NK cell activation via CD16A D 205 > A was not increased, suggesting that, although the D 205 > A mutant reaches the surface very efficiently, the association with FceR1γ and/or CD247 is only partially intact. Overall, these observations strongly support our prior conclusions that the CD16A TM residues F 202 and T 206 mediate important contacts with the signaling adaptor molecules. Although D 205 also contributes to these interactions, the major role of this amino acid seems to be to influence the intracellular trafficking of the receptor.
Structural Model of the Interface Between CD16A and Signaling Adaptors. To gain insight into how the residues identified in our mutagenesis experiments contribute to assembly with CD247 and FceR1γ, we performed replica exchange molecular dynamics (REMD) simulations in an implicit bilayer model examining possible modes of association of the CD16A TM domain with dimeric signaling adaptors. A 30-aa CD16A fragment encompassing the predicted α-helical TM domain was tested in unrestrained assembly simulations with the previously reported CD247 TM dimer structure (24) (Fig. S4) and with an FceR1γ dimer modeled on this structure (Fig. 7 A and D) (simulation parameters are described in Materials and Methods). Cluster analysis of the resulting trimeric models revealed a clearly favored conformation for each simulation in which the polar/aromatic face identified in our mutagenesis screen mediates extensive contacts to the composite surfaces formed by the CD247 (Fig. S4 ) and FceR1γ dimers (Fig. 7 A and  D) . Of 1,000 structures randomly chosen for analysis from the CD16A-CD247 simulation (Fig. S4) , 931 clustered together with only 1.21 Å average root mean square deviation (rmsd) compared with the centroid structure. For CD16A-FceR1γ (Fig. 7 A and D) , 800/1,000 structures clustered together with an average rmsd of 1.58 Å compared with the centroid structure. The two representative models from these independent simulations were essentially identical, with only 0.61 Å rmsd between the centroid structures.
In the trimeric complex structures, the F 202 D 205 T 206 trio that accounted for the most severe assembly defects in our screen of CD16A mutants forms the central core of the trimeric interface through highly favorable polar and van der Waals contacts. Comparison of the trimeric structures with the previously reported solution NMR structure of the CD247 dimer alone (Fig. S4) showed that one side of a symmetrical tyrosine-threonine hydrogenbond pair that is essential for CD247 dimer formation (24) (Fig. S3) . Statistical significance was calculated using one-way ANOVA-Dunnett posttest for multiple comparison (*P < 0.05; **P < 0.01; ***P < 0.001; n.s., not statistically significant P > 0.05). ) ( Fig. S4  and Fig. 7D ). CD16A F 202 contributes to the surface complementarity in this region by occupying a cavity at G 13 that is present in the interface of both signaling dimers (see surface representations in Fig. S4 ). Because the "rear" Y 12 -T 17 hydrogen bond in the signaling dimer is maintained, these new contacts to CD16A create a "belt" of hydrogen bonds in the lipid bilayer interior that constitutes a major stabilizing feature of the trimeric assembly. Although the relatively mild effect of alanine substitution at D 205 suggests that loss of this hydrogen bond alone is not sufficient to abrogate assembly, its interior position in the closely packed interface explains why larger side-chains were not tolerated (Fig. 3) .
The interactions near the outer (at the top of Fig. 7 ) and inner (at the bottom of Fig. 7 ) limits of the membrane also show interfacial contacts involving residues identified in our mutagenesis experiments. CD16A Q 191 is positioned to make contacts to one of the aspartic acids in the signaling dimer whereas F 194 also packs closely against the aspartic acid pair, where it may contribute favorable π-electronic interactions (25) . Of the two aromatic residues at the bottom of the CD16A TM helix, only Y 209 contacts the signaling dimer, fitting neatly into a groove between two aliphatic residues one helical turn apart in the signaling dimer (see surface representations in Fig. S4 ). The detrimental effects of mutations at F 210 , which faces away from the interface, may be due to a role in stabilizing CD16A membrane insertion, a role commonly ascribed to aromatic residues near the inner leaflet of the lipid bilayer. Of the Fc receptors that require assembly with dimeric FceR1γ (CD16A, FceR1, FcγR1/CD64, and FcαR1/CD89), only CD89 contains a basic amino acid in its TM domain for assembly. Like CD16A, FceR1α and CD64 both contain FxxDT-like sequences in their TM domains (FxxDT in FceR1α and FxxNT in CD64). Given this sequence similarity and others ( Fig. 8 A and B) , we sought to determine whether these receptors could form comparable TM interfaces with the signaling adaptor. In independent and unrestrained REMD simulations of assembly with FceR1γ dimers in a . Cells expressing CD16A at the cell surface are marked by a square. The mean fluorescence intensity (MFI) of cells expressing CD16A at the cell surface staining (B) was analyzed using Kaluza Flow Cytometry Analysis Software. Western blots analyzing total CD16A protein expression (C and E) was quantified using ImageJ and plotted after normalization to GFP as a control for transfection efficiency (D and F). Statistical significance was calculated using one-way ANOVA-Dunnett post test for multiple comparison (*P < 0.05; **P < 0.01; ***P < 0.001; n.s., not statistically significant P > 0.05). > A mutants were functionally tested in ADCC and redirected lysis experiments. NK cells were cultivated alone or in combination with Raji or P815 cell lines loaded, or not, with αCD20 (Rituximab) and CD16-specific mAb (3G8), respectively. After 2-h coculture, CD107a staining was measured by flow cytometry. Data represent mean of three experiments, and statistical significance was calculated using one-way ANOVA-Dunnett posttest for multiple comparison (**P < 0.01; ***P < 0.001; n.s., not statistically significant P > 0.05). model membrane, both receptor TM domains indeed converged on very similar interfaces to that observed in the CD16A simulations. The models shown in Fig. 7 B and C represent the majority clusters in each assembly: 726/1,000 FceR1α-FceR1γ structures analyzed clustered together with an average rmsd of 1.40 Å compared with the centroid (Fig. 7B) , and 839/1,000 CD64-FceR1γ structures clustered together with average rmsd of only 1.10 Å compared with the centroid (Fig. 7C) . Consistent with sequence differences in the N-terminal regions of the three TM domains, the major contacts to FceR1γ at the outer membrane limit are variable. FceR1α has a glutamine in the same position as CD16A Q 191 , and, although it does not contact the aspartic acid pair in the centroid model shown (Fig. 7B) , hydrogen bonds to the acidic side-chains are sampled in ∼27% of structures in the majority cluster, suggesting that this polar residue may indeed play a similar role to Q 191 in CD16A. In FceR1α, an isoleucine (I) takes the place of CD16A F 194 . In the CD64 model (Fig. 7C) , the position of CD16A F 194 is maintained, but neighboring histidine (H) and tyrosine (Y) residues provide the polar contacts to FceR1γ aspartic acids. At the inner membrane limit (bottom), both receptors contain an aromatic residue in the position of CD16A Y 209 (F in FceR1α; W in CD64). Remarkably, the FxxDT trio in FceR1α and the FxxNT trio in CD64 established contacts to FceR1γ dimers essentially identical to those we observed in the CD16A assembly models (Fig. 7 D-F) . The similar role of aspartic acid and asparagine in these assembly models is fully consistent with the outcome of the D 205 > N mutation in CD16A IVT experiments (Fig. 3) , which we found was well-tolerated. These results indicate that Fc receptors without basic TM residues may all assemble based on core TM interactions similar to those we described for CD16A above.
We tested this hypothesis for one of the two additional receptors, FceR1α, by examining the role of the FxxDT sequence in assembly and surface expression in cells (Fig. 8) . Consistent with previous data (26), WT FceR1α chain was not expressed at the cell surface unless cotransfected with FceR1γ ( Fig. 8 C and D) T 220 > A triple mutant was unable to reach the cell surface regardless of whether FceR1γ was coexpressed or not (compare Fig. 8 C and E) . This observation confirms a role for this sequence in assembly but suggests that, unlike CD16A D 205 , FceR1α D 219 does not play a dominant role in intracellular retention. This idea is consistent with previous data (27, 28) . A Western blot analysis (Fig. 8E) shows that the F 216 D 219 T 220 > A mutant does accumulate intracellular protein to a much greater level than WT FceR1α although it does not progress through the endocytic pathway and acquire mature glycosylation, suggesting that the D 219 residue does play some role in regulating the turnover of FceR1α protein. As in CD16A, substitution of either the F 216 or T 220 residues with alanine significantly reduced the ability of cotransfected FceR1γ to promote receptor expression at the cell surface (Fig. 8E) , and together these two mutations account for most of the expression defect observed in the triple mutant. These data show that FceR1α assembles with its signaling adaptor through a similar core TM arrangement as CD16A.
Discussion
A key feature underlying the formation of activating immune receptor complexes is the formation of an interface between the TM helix of the ligand-binding receptor subunit and the paired TM helices of the dimeric adaptor module that is crucial for intracellular signaling. In this paper, we have characterized how TM helices can associate to form an activating immunoreceptor complex in the absence of complementary charge potential and have gone on to show that a subset of the residues in the receptor TM domain that mediate association with the adaptor molecules also have a marked influence on the cell biology of the receptor.
Many activating immunoreceptors associate with signaling adaptor molecules via the interaction of a basic amino acid in the TM domain of the receptor with a pair of acidic residues in the TM region of the dimeric signaling module (10) . However, our studies of the complex formed between CD16A and the signaling adaptor molecules FceR1γ and CD247 have revealed that this three-helix interface can also form via interactions between polar and aromatic residues extending over the whole length of the TM domain. In this mode of association, multiple residues located on a single aspect of the receptor TM helix contribute to the interaction with the signaling dimer. These data contrast markedly with receptor complexes such as KIR2DS2-DAP12 and NKG2D-DAP10, wherein a single, properly placed lysine or arginine residue within a polyvaline or polyleucine TM sequence is sufficient for interaction with a pair of aspartic acid residues in the signaling adaptor module and cell surface expression (14) . It has been argued that focusing the interaction of signaling adaptor molecules on a single charged residue facilitates the interaction of these adaptors with multiple receptor TM domains with widely varying sequences (14) , but our data demonstrate that CD247 and FceR1γ can also enlarge the repertoire of receptors with which they interact by associating with TM domains in more than one way. Indeed, it could be argued that the mode of interaction of FceR1γ or CD247 with CD16A might, in evolutionary terms, be more robust because there is no one pair of interacting residues that is absolutely critical and so multiple mutations would have to occur to ablate this association.
Our independent and unbiased REMD simulations are in excellent agreement with the mutagenesis analysis, identifying the polar/aromatic face of the CD16A TM domain as the key assembly surface and reaching nearly identical conformations for assembled CD16A-CD247 and CD16A-FceR1γ complexes. Similar to the previously published solution NMR structure of the NKG2C-DAP12 trimeric TM complex (29) , the receptor TM helix is predicted to bind along an extended groove formed by the interface of the two signaling module α-helices. However, where NKG2C assembly is governed by a single, centrally located lysine residue binding to the paired DxxxT motifs in DAP12, CD16A establishes a more extensive interface, dependent on polar and aromatic residues, with CD247/FceR1γ that is anchored around the central F 202   D   205   T 206 trio but also has significant contributions at both ends of the helices. Thus, the modeling data strongly support the suggestion from the experimental data that interactions involving specific polar and aromatic residues of CD16A are critical for the association between the receptor and adaptor molecules.
The rearrangement of the previously described CD247 interface (24) to accommodate the new contacts to CD16A is striking in view of the recent report suggesting that CD247 also undergoes a significant structural alteration upon incorporation into the TCR-CD3 complex (30) , and this flexibility may be particularly important for the demonstrated ability of both CD247 and FceR1γ to form stable assemblies with many different receptor TM sequences. Interestingly, despite the apparent interchangeability of human FceR1γ and CD247, murine CD247 is essentially unable to function in the assembly of either human or mouse CD16A so that, in murine NK cells, only FceR1γ participates in the assembly of this receptor complex (4) . This phenotype has been mapped to an isoleucine for leucine change in murine CD247 (16) T 206 sequence in our models (Fig. S5 ). This positioning suggests that the β-branched structure of isoleucine is disruptive to the central intermolecular packing motif, providing a molecular explanation for the inability of murine CD247 to associate with CD16A and additional support for our assembly model.
The observation that CD16A associates equally well with human CD247 and FceR1γ homodimers, as well as the heterodimer (Fig.  1 ), is consistent with the convergence of the modeling results. It therefore seems likely that the major factors influencing whether CD16A associates with CD247 or FceR1γ are related to the relative levels of expression of the different adaptors and possible competition from other receptors that also bind CD247 and FceR1γ. For example, a population of terminally differentiated human NK cells lose expression of FceR1γ (31) , and, in these cells, CD16A associates exclusively with CD247 (15) . In contrast, the majority of circulating human NK cells express both FceR1γ and CD247, but they also express multiple NK receptors that associate with these adaptor molecules. These receptors show little sequence similarity between their TM domains, and it is possible that they recruit CD247 and FceR1γ unequally from the pool of available adaptors because an interaction between amino acids of complementary charge in the hydrophobic core of the lipid bilayer could differ in "affinity" from one that depends on interactions involving polar and aromatic residues. It is also possible that the specificity of the interaction could be modulated by steric hindrance between domains of the receptors flanking the TM region (13, 14) .
Apart from the mechanism of association of CD16A with FceR1γ and CD247, the other striking observation emerging from these experiments is that D 205 within the CD16A TM, unless sequestered within the three-helix interface upon assembly with either FceR1γ or CD247, promotes intracellular retention of the receptor. It has long been appreciated that the formation of specific polar contacts between TM domain amino acids is a key mechanism to ensure the accurate assembly of multicomponent protein complexes to be expressed on the cell surface (9, 10) and that, in the absence of these contacts, unassembled subunits and partially formed complexes are retained intracellularly and eventually degraded (32) . In the case of the TCR, it is the same charged residues providing the core assembly contacts that mediate this qualitycontrol function. In contrast, we found that CD16A D 205 makes only a limited contribution to the receptor/adaptor interaction, but its sequestration within the assembly interface seems to act as a quality control mechanism to ensure that only complete receptor complexes can traffic to the cell surface. Thus, in CD16A, the quality-control function has been separated, at least partially, from the assembly function although both are still located in the TM domain. This FxxDT sequence is highly conserved among the predicted TM sequences of CD16A from multiple mammalian species (Fig. 8A) and is also present in FceR1α and CD64 (as FxxNT) (Fig. 8B) , both of which formed trimeric complexes with FceR1γ in our assembly simulations that used CD16A-like interfaces (Fig. 7) . Indeed, mutation of these residues in FceR1α caused loss of surface expression and intracellular retention of the receptor, indicating that this sequence also regulates cell-surface expression of FceR1α, most likely through assembly with FceR1γ. In contrast to our observations with CD16A, the FDT triple mutant of FceR1α was not expressed at the cell surface in the absence of adaptor molecules, but the large accumulation of intracellular protein detected by Western blot suggests that mutation of the aspartic acid did indeed protect unassembled FceR1α protein from degradation. The lack of cell surface expression of this mutant likely reflects the action of ER retention motifs present in the cytoplasmic tail of this receptor that have previously been identified as key elements regulating the trafficking of FceR1α to the plasma membrane (27, 28) .
Overall, these data strongly suggest that the Fxx(D/N)T sequences found in three different Fc receptor TM domains form the core membrane-embedded interaction motifs that drive assembly with signaling adaptor molecules and, at least in a subset of these receptor complexes, regulate receptor protein turnover. Thus, at least two completely different solutions for TM-mediated receptor assembly with CD247/FceR1γ signaling modules have arisen during evolution, one driven by a single basic TM residue and another based on the more complex polar/aromatic interface described here. These findings may provide more broadly useful insights into the biology of other immune receptors that do not contain charged residues in their TM domains and how they assemble into complexes with signaling adaptor molecules.
Materials and Methods
Transmembrane Domain Mutagenesis. A WT human FcγRIIIA (CD16A) sequence was amplified by PCR and cloned into a modified pSP64 vector (11) for coupling to a streptavidin binding protein (SBP) tag. FceR1γ was amplified and cloned into a vector bearing an HA tag. The CD247 construct has been described previously (11) . Multiple and single amino acid substitutions in CD16A were generated by QuikChange PCR-based mutagenesis. The sequences of the oligonucleotides used for cloning and mutagenesis are shown in Table S1 . The integrity of all WT and mutant CD16A, FceR1γ, and CD247 constructs was verified by sequencing (GATC-Biotech). In some cases, CD16A WT and mutant cDNAs were then subcloned into the lentiviral vector pHRSIN-C56W-UbEM (a gift of Paul Lehner, Cambridge Institute for Medical Research, Cambridge, United Kingdom) to simultaneously express CD16A under the SFFV promoter and the GFP derivative protein, Emerald, under a ubiquitin promoter. A cDNA clone encoding the mature FceR1α cDNA was amplified by PCR and cloned into the pMX-HA puro vector (a gift of Chiwen Chang, Department of Pathology, University of Cambridge, Cambridge, UK) for expression as an N-terminally HA-tagged protein.
In Vitro Translation Assay. In vitro-transcribed mRNAs encoding all full-length receptor subunits and mutants were pretested for matched translation and ER microsome import. CD16A, FceR1γ, and CD247 were then cotranslated in the presence of ER microsomes for 30 min at 30°C before addition of oxidized glutathione (4 mM final concentration) to initiate oxidative folding and assembly. After a further 2-h incubation at 30°C, the completed assembly reactions were stopped by dilution in 0.5 mL of ice-cold Tris-buffered saline (TBS) (pH 8) containing 10 mM iodoacetamide. The membrane fraction was collected by centrifugation and washed with cold TBS before extraction with 1% digitonin in TBS containing 10 mM iodoacetamide to block disulphide bond formation after extraction and during handling. Lysates were cleared by centrifugation and immunoprecipitated with antibody-coupled agarose beads (4°C for 2 h). Final products were eluted in SDS, separated on 12% NuPAGE gels (Life Technologies) under nonreducing conditions and transferred to PVDF membranes for phospho-imaging.
Cell Lines. Cells were maintained at 37°C and 5% CO 2 in a humidified incubator and split as necessary. The 293T cell line was cultivated in Dulbecco´s modified Eagle's medium (DMEM) with 10% FCS. NKL and NK92-MI cells were grown in RPMI with 5% FCS, 5% human serum, and 50 U/mL IL-2 (Peprotech). Media were supplemented with 2 mM L-glutamine, 0.1 mM sodium pyruvate, 100 U/mL penicillin, 100 U/mL streptomycin, and 50 μM β-mercaptoethanol. The 293T cells were transfected with plasmids bearing CD16A WT or mutant constructs using the jetPEI transfection reagent. Twenty-four hours after transfection, cells were either lysed or recovered for flow cytometry analysis. Lentiviral transduction was used to express CD16A and mutants in NKL and NK92-MI cell lines.
Lentiviral Gene Transduction. Lentiviruses were generated by transfection of 293T cells with the indicated lentivector together with the plasmids pCMVR8.91 and pMD2G. Two days after transfection, the culture media containing the lentiviruses were harvested, filtered, and stored at −80°C. For each lentiviral transduction, 0.1 × 10 6 cells were mixed with 0.75 mL of virus supernatant in the presence of either 1 μM TBK1 inhibitor BX795 (InvivoGen), 8 μg/mL protamine sulfate (Sigma-Aldrich), and 50 U/mL IL-2 (NKL and NK92-MI cells) and seeded in five wells of a 96-well plate (BD Biosciences). The plates were then centrifuged at 120 × g for 1 h at 33°C. After centrifugation, without removing viral supernatants, the plates were incubated at 37°C, 5% CO 2 for 4 to 6 h and then spun again at 120 × g for 1 h at 33°C. The supernatants were then removed from the wells, and fresh growth medium was added.
Flow Cytometry. Cells were washed and incubated in PBS/0.5% (wt/vol) BSA/ 1% (vol/vol) FBS/0.1% sodium azide buffer (PBA buffer) and stained using purified CD16A-specific mAb (3G8) or the HA-specific mAb 12CA5, followed by anti-mouse-Ig coupled to PE (phyco-erythrin) (Dako Cytomation) for 30 min at 4°C. Cells were analyzed using FACSCalibur (BD Biosciences) and Gallios (Beckman Coulter) cytometers. Data were analyzed with FlowJo and Kaluza Flow Cytometry Analysis programs.
Degranulation Assay. For degranulation assays quantifying cell surface CD107a expression, 1 × 10 5 resting NK92MI cells were washed twice in PBS and added to 2 × 10 5 target cells in 200 μL of complete medium. Two target cells were used in these antibody-dependent cell-mediated cytotoxicity (ADCC) and redirected cytotoxicity experiments; Raji cells and P815 cells sensitized, or not, with Rituximab or the CD16-specific mAb 3G8, respectively (33) . Cells were spun down for 3 min at 100 × g and incubated for 2 h at 37°C in 5% CO 2 . The cells were then washed once in ice-cold PBS/2% BSA/2mM EDTA/0.05% sodium azide (PBA) and stained with PE-conjugated anti-CD94 for NK cell gating and APC-conjugated antiCD107a mAbs for 30 min at 4°C. The cells were washed, resuspended in PBA, and analyzed by flow cytometry.
Western Blot. Cells were collected, washed once with ice-cold PBS, and lysed in radioimmunoprecipitation assay (RIPA) lysis buffer [50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS with protease inhibitors (1 μM pepstatin A, 1 μM leupeptin)] and 0.5 mM iodoacetamide for at least 30 min on ice. Lysates were centrifuged to pellet insoluble material for 15 min at 4°C and then quantified; 25 to 30 μg of protein were loaded onto 8 to 12% SDS reducing polyacrylamide gels and electrophoresed, followed by transfer to PVDF (Immobilon-P; Millipore). Membranes were blocked in 5% dried skimmed milk (1 h, 25°C), washed three times in 0.05% Tween/TBS, and incubated (overnight, 4°C) in primary antibodies: mouse monoclonal anti-CD16A (clone DJ130c), rabbit polyclonal anti-GFP (both from Santa Cruz Biotechnology), mouse monoclonal anti-β actin (Sigma Aldrich), or 3F10 (HAspecific; Roche) in 0.05% Tween/TBS. Membranes were then washed in 0.05% Tween/TBS (5 min, 2×), and bound antibodies were visualized using goat anti-mouse or goat anti-rabbit secondary reagents (Dako Cytomation) and the ECL-Western Blot Detection Reagent (GE Healthcare). For EndoH treatment, a 25-μg sample was denatured for 10 min at 100°C and treated with 0.25 units of EndoH enzyme (New England Biolabs) for 1 h at 37°C and visualized as mentioned before. Western quantification was carried out using ImageJ and normalized against GFP as reporter of transfection efficiency.
